Dyne Therapeutics, Inc. · NASDAQ:DYN
Lucera Erick sold 1,448 Dyne Therapeutics, Inc. shares (Form 4)
Traded May 13, 2026 · Filed May 14, 2026
On May 13, 2026, Lucera Erick (Chief Financial Officer) sold 1,448 Dyne Therapeutics, Inc. shares at US$18.36 for US$26,585 under a trading plan, leaving 123,925 shares. Filed May 14, 2026 (Form 4).
- Sold
- 1,448 shares
- Price
- US$18.36
- Value
- US$26,585
- Holding after
- 123,925 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 13, 2026 | Common Stock | Sale | 1,448 | US$18.36 | 123,925 | Direct |
Source
Related
- Dyne Therapeutics, Inc.
- Lucera Erick
- Dyne Therapeutics, Inc. shareholders
- Form 4 · Lucera Erick · Aug 17, 2026
- Form 4 · Lucera Erick · Jun 26, 2026
- Form 4 · Lucera Erick · Apr 3, 2026
- Form 4 · Posner Brian S · Oct 6, 2026
- Form 4 · Friedl-Naderer Johanna · Sep 8, 2026
- Form 4 · Cox John · Sep 8, 2026
- Form 4 · Kerr Douglas · Sep 8, 2026
- Form 4 · Rhodes Jason P · Aug 17, 2026